Positive Phase III results for linerixibat in cholestatic pruritus treatment for PBC patients
GSK has announced positive headline results of its ongoing global Phase III clinical trial GLISTEN, which is evaluating the use…
News
Yonalink launches ICTN to position Israel as leader in clinical trial innovation
Research finds DLBCL patients starting treatment immediately face worse outcomes
Concerto doses first subject in Phase I trial of ENS-002 for atopic dermatitis
Veeva Commercial Summit: Increased investment in medical affairs by pharma companies
WideTrial backs NIH access program for investigational ALS drug
GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment
MSD reports topline outcomes from Phase III NSCLC trial of pembrolizumab
